These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35122751)

  • 1. The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer.
    Meadows-Taylor MB; Faris NR; Smeltzer MP; Ray MA; Fehnel C; Akinbobola O; Ariganjoye F; Patel A; Pacheco A; Mehrotra A; Fox R; Optican R; Tonkin K; Machin J; Wright J; Robbins ET; Osarogiagbon RU
    Chest; 2022 Jul; 162(1):242-255. PubMed ID: 35122751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer.
    Stokes SM; Massarweh NN; Stringham JR; Varghese TK
    Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    Osarogiagbon RU; Lee YS; Faris NR; Ray MA; Ojeabulu PO; Smeltzer MP
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1220-1229.e2. PubMed ID: 31147169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer.
    Vest MT; Tanoue L; Soulos PR; Kim AW; Detterbeck F; Morgensztern D; Gross CP
    J Thorac Oncol; 2012 Jan; 7(1):188-95. PubMed ID: 22134069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Mediastinal Staging Guideline Concordance.
    Bendzsak A; Waddell TK; Yasufuku K; Keshavjee S; de Perrot M; Cypel M; Pierre AF; Darling GE
    Ann Thorac Surg; 2017 Jun; 103(6):1736-1741. PubMed ID: 28262300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
    Tandberg DJ; Gee NG; Chino JP; D'Amico TA; Ready NE; Coleman RE; Kelsey CR
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):796-801. PubMed ID: 23870158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
    Nadpara P; Madhavan SS; Tworek C
    Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality gaps and comparative effectiveness in lung cancer staging and diagnosis.
    Ost DE; Niu J; Elting LS; Buchholz TA; Giordano SH
    Chest; 2014 Feb; 145(2):331-345. PubMed ID: 24091637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
    Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
    Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to the mediastinal staging guideline and unforeseen N2 disease in patients with resectable non-small cell lung cancer: Nationwide results from the Dutch Lung Cancer Audit - Surgery.
    Bousema JE; Heineman DJ; Dijkgraaf MGW; Annema JT; van den Broek FJC
    Lung Cancer; 2020 Apr; 142():51-58. PubMed ID: 32088606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.
    Amini A; Correa AM; Komaki R; Chang JY; Tsao AS; Roth JA; Swisher SG; Rice DC; Vaporciyan AA; Lin SH
    Ann Thorac Surg; 2012 Sep; 94(3):914-20. PubMed ID: 22819472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
    Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.
    Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Levy P; Wiggins L; Sachdev V; Robbins T; Spencer D; Osarogiagbon RU
    Ann Thorac Surg; 2018 Jul; 106(1):228-234. PubMed ID: 29534956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States.
    Nadpara PA; Madhavan SS; Tworek C; Sambamoorthi U; Hendryx M; Almubarak M
    J Geriatr Oncol; 2015 Mar; 6(2):101-10. PubMed ID: 25604094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.
    Osarogiagbon RU; Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Signore RS; McHugh LM; Levy P; Wiggins L; Sachdev V; Robbins ET
    Ann Thorac Surg; 2017 May; 103(5):1557-1565. PubMed ID: 28366464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.
    De Leyn P; Dooms C; Kuzdzal J; Lardinois D; Passlick B; Rami-Porta R; Turna A; Van Schil P; Venuta F; Waller D; Weder W; Zielinski M
    Eur J Cardiothorac Surg; 2014 May; 45(5):787-98. PubMed ID: 24578407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.